Artificial cornea implant aims to restore sight in the blind
NCT ID NCT05694247
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This trial tested a device called the CorNeat KPro, an artificial cornea, in 15 legally blind adults who could not get a standard cornea transplant. The goal was to see if the implant is safe and can improve vision. The study was terminated early, so full results are not available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
CorNeat KPro (artificial cornea implant)
What this could lead to
If successful, this device could offer a new option to restore vision in people with corneal blindness who cannot have a standard cornea transplant.
What could go wrong
This was a small, early trial that was terminated, so results are limited. The device may fail to stay in place or cause complications like infection or rejection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORNEAL OPACITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Amsterdam UMC - Location AMC
Amsterdam, 1105 AZ, Netherlands
-
CHU de Montpellier
Montpellier, 34295, France
-
Hopital Fondation Adolphe de Rothschild
Paris, France
-
Rabin Medical Center - Beilinson
Petah Tikva, Israel, 4941492, Israel
-
UHN - University Health Network
Toronto, Ontario, M5T 2S8, Canada
-
University of British Columbia
Vancouver, British Columbia, V5Z 3N9, Canada